Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	May 27, 2022	May 28, 2021	May 27, 2022		May 28, 2021
Income Statement [Abstract]
Net sales	$ 462,540	$ 437,728	$ 1,381,655	[1]	$ 1,033,433	[1]
Cost of sales	348,077	353,241	1,032,278		842,847
Gross profit	114,463	84,487	349,377		190,586
Operating expenses:
Research and development	20,298	16,718	56,749		32,534
Selling, general and administrative	58,732	48,475	164,396		118,195
Change in fair value of contingent consideration	124	16,400	41,324		16,400
Total operating expenses	79,154	81,593	262,469		167,129
Operating income	35,309	2,894	86,908		23,457
Non-operating (income) expense:
Interest expense, net	5,110	5,049	14,678		12,568
Other non-operating (income) expense	550	489	3,570		1,187
Total non-operating (income) expense	5,660	5,538	18,248		13,755
Income (loss) before taxes	29,649	(2,644)	68,660		9,702
Income tax provision	5,154	4,010	20,495		8,485
Net income (loss)	24,495	(6,654)	48,165		1,217
Net income attributable to noncontrolling interest	382	557	1,567		557
Net income (loss) attributable to SGH	$ 24,113	$ (7,211)	$ 46,598		$ 660
Earnings (loss) per share:
Basic (in usd per share)	$ 0.48	$ (0.15)	$ 0.94		$ 0.01
Diluted (in usd per share)	$ 0.44	$ (0.15)	$ 0.84		$ 0.01
Shares used in per share calculations:
Basic (in shares)	50,095	48,071	49,543		48,542
Diluted (in shares)	54,998	48,071	55,756		51,167

[1] Sales to related parties were de minimis in 2022 and were $20,103 and $53,251 in the three and nine months ended May 28, 2021, respectively.